Takeda: Advancing the Potential for Off-the-Shelf, Highly Scalable and Lower Cost CAR T-Cell Therapy for Cancer Treatment.

CiRA, Takeda  & T-CiRA Less than five years ago the Center for iPS Cell Research and Application (CiRA) 1   at Kyoto University and Takeda   Pharmaceutical ( TAK ) 2 established a research program. To...